If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Directorate Change

14 Jun 2012 16:15

RNS Number : 4114F
Arden Partners plc
14 June 2012
 



14 June 2012

 

Arden Partners plc ("Arden" or the "Company")

Directorate Change

The Board of Arden are pleased to announce the appointment of James Clive Reed-Daunter as an Executive Director of the Company with immediate effect following regulatory approval by the FSA.

Mr Reed-Daunter, 42, is a member of the senior management team at Arden and has a beneficial holding of 1,185,251 ordinary shares of 10 pence each in the Company, representing 4.78 per cent of the current issued share capital of the Company.

There is no other information that is required to be disclosed under schedule 2(g) of the AIM rules for Companies.

 

Arden Partners plc

0207 614 5900

Jonathan Keeling - Chief Executive Officer

 

Trevor Norris - Group Finance Director

 

 

 

Altium - NOMAD to Arden Partners plc

0207 484 4040

Phil Adams

 

Sam Fuller

 

 

Buchanan Communications

0207 466 5000

Mark Edwards

 

Nicola Cronk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABUGDLLGBBGDS
Date   Source Headline
9th Jun 200910:18 amRNSEPT Disclosure
8th Jun 200911:03 amRNSEPT Disclosure
5th Jun 200910:29 amRNSEPT Disclosure
3rd Jun 200911:06 amRNSEPT Disclosure
2nd Jun 20099:31 amRNSEPT Disclosure
1st Jun 20093:59 pmRNSEPT Disclosure - Amendment
1st Jun 200911:06 amRNSEPT Disclosure
29th May 200910:21 amRNSEPT Disclosure
28th May 200911:29 amRNSEPT Disclosure
27th May 20099:31 amRNSEPT Disclosure
26th May 200910:52 amRNSEPT Disclosure
22nd May 20091:00 pmRNSBlock Admission
21st May 200910:30 amRNSEPT Disclosure
20th May 200911:19 amRNSEPT Disclosure
19th May 20099:53 amRNSEPT Disclosure
18th May 20099:35 amRNSEPT Disclosure
15th May 20099:45 amRNSEPT Disclosure
14th May 200910:30 amRNSEPT Disclosure
13th May 200910:58 amRNSEPT Disclosure
11th May 20095:23 pmRNSHolding(s) in Company
11th May 200910:18 amRNSEPT Disclosure
7th May 200912:27 pmRNSEPT Disclosure
6th May 200912:02 pmRNSEPT Disclosure
5th May 200911:51 amRNSDirector's dealing
30th Apr 20094:05 pmRNSAdditional Listing and EBT Purchase
30th Apr 200910:30 amRNSEPT Disclosure
24th Apr 200910:28 amRNSEPT Disclosure
23rd Apr 20099:53 amRNSResult of AGM
22nd Apr 20097:00 amRNSAnnual General Meeting 2009: Statement
21st Apr 200910:59 amRNSEPT Disclosure
20th Apr 200911:36 amRNSEPT Disclosure
9th Apr 20092:21 pmRNSCompletion of Tender
8th Apr 200911:22 amRNSDirector's dealing
26th Mar 200910:26 amRNSEPT Disclosure
18th Mar 200912:01 pmRNSEPT Disclosure
17th Mar 200910:49 amRNSEPT Disclosure
16th Mar 20092:30 pmRNSAnnual Report and Accounts
6th Mar 20094:04 pmRNSDirector Declaration
2nd Mar 20093:58 pmRNSDirector Declaration
3rd Feb 20094:33 pmRNSDirector/PDMR Shareholding
3rd Feb 20094:31 pmRNSHolding(s) in Company
3rd Feb 20097:00 amRNSDirector's dealing
30th Jan 20094:20 pmRNSEBT Disposal
16th Jan 20094:11 pmRNSEBT Purchase
16th Jan 20094:10 pmRNSHolding(s) in Company
13th Jan 200910:12 amRNSEPT Disclosure
13th Jan 20097:00 amRNSPreliminary Results
9th Jan 20092:48 pmRNSEPT Disclosure
9th Jan 20092:46 pmRNSEPT Disclosure-Amendment
9th Jan 200910:01 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.